The nation’s most prescribed oral COVID-19 treatment — which reduced COVID-19 hospitalizations and deaths by 89 percent in a phase 2/3 study — has nearly 3 million orders with more than 1 million prescriptions filled, according to a June 1 HHS report.
The deal “will allow Pfizer to increase supply by an additional 4 million packs of Paxlovid, allowing us to meet global demand and help increase overall access,” Pfizer spokesperson Julia Cohen told The Hill.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.